CN107412766A - 二糖合成脂质化合物及其用途 - Google Patents

二糖合成脂质化合物及其用途 Download PDF

Info

Publication number
CN107412766A
CN107412766A CN201710534045.0A CN201710534045A CN107412766A CN 107412766 A CN107412766 A CN 107412766A CN 201710534045 A CN201710534045 A CN 201710534045A CN 107412766 A CN107412766 A CN 107412766A
Authority
CN
China
Prior art keywords
compound
synthetic
alkyl
unsubstituted alkyl
diglycolipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710534045.0A
Other languages
English (en)
Chinese (zh)
Inventor
沃尔特·A·肖
斯蒂芬·W·伯吉斯
盛荣·李
D·T·希克曼
M·P·洛佩兹德贝尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AC Immune SA
Avanti Polar Lipids Inc
Original Assignee
AC Immune SA
Avanti Polar Lipids Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AC Immune SA, Avanti Polar Lipids Inc filed Critical AC Immune SA
Publication of CN107412766A publication Critical patent/CN107412766A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN201710534045.0A 2012-04-12 2013-04-12 二糖合成脂质化合物及其用途 Pending CN107412766A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261623393P 2012-04-12 2012-04-12
US61/623,393 2012-04-12
US13/842,424 US9241988B2 (en) 2012-04-12 2013-03-15 Disaccharide synthetic lipid compounds and uses thereof
US13/842,424 2013-03-15
CN201380026285.XA CN104470938B (zh) 2012-04-12 2013-04-12 二糖合成脂质化合物及其用途

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201380026285.XA Division CN104470938B (zh) 2012-04-12 2013-04-12 二糖合成脂质化合物及其用途

Publications (1)

Publication Number Publication Date
CN107412766A true CN107412766A (zh) 2017-12-01

Family

ID=49325307

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201710534045.0A Pending CN107412766A (zh) 2012-04-12 2013-04-12 二糖合成脂质化合物及其用途
CN201380026285.XA Active CN104470938B (zh) 2012-04-12 2013-04-12 二糖合成脂质化合物及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201380026285.XA Active CN104470938B (zh) 2012-04-12 2013-04-12 二糖合成脂质化合物及其用途

Country Status (9)

Country Link
US (2) US9241988B2 (cg-RX-API-DMAC7.html)
EP (2) EP3674309B1 (cg-RX-API-DMAC7.html)
JP (3) JP6271510B2 (cg-RX-API-DMAC7.html)
CN (2) CN107412766A (cg-RX-API-DMAC7.html)
CA (1) CA2870008C (cg-RX-API-DMAC7.html)
DK (1) DK3674309T3 (cg-RX-API-DMAC7.html)
ES (2) ES2992314T3 (cg-RX-API-DMAC7.html)
IN (1) IN2014DN09392A (cg-RX-API-DMAC7.html)
WO (1) WO2013155448A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2468300B1 (en) 2006-09-26 2017-12-20 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US9241988B2 (en) * 2012-04-12 2016-01-26 Avanti Polar Lipids, Inc. Disaccharide synthetic lipid compounds and uses thereof
SMT201800368T1 (it) 2012-05-16 2018-09-13 Immune Design Corp Vaccini per l'infezione da virus-2 herpes simplex
US9504743B2 (en) 2013-09-25 2016-11-29 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US20150086592A1 (en) 2013-09-25 2015-03-26 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149521B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149522B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
CN107073105B (zh) * 2014-09-12 2021-04-06 巴斯特威尔控股有限公司 用于提供含佐剂病毒体的方法及由此可获得的含佐剂病毒体
CN107405395A (zh) * 2015-03-17 2017-11-28 红杉科学有限公司 疫苗与佐剂的组合物以及治疗尿路感染的方法
EP3069729A1 (en) * 2015-03-17 2016-09-21 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
WO2020055503A1 (en) 2018-09-14 2020-03-19 Massachusetts Institute Of Technology Nanoparticle vaccine adjuvant and methods of use thereof
CA3118692A1 (en) 2018-11-06 2020-05-14 Alsatech, Inc. Cell-based gene therapy for neurodegenerative diseases
EP3886901A1 (en) * 2018-11-29 2021-10-06 GlaxoSmithKline Biologicals S.A. Methods for manufacturing an adjuvant
BR112022008761A2 (pt) 2019-11-22 2022-07-26 Glaxosmithkline Biologicals Sa Dosagem e administração de uma vacina de glicoconjugado de sacarídeo
WO2023114570A1 (en) 2021-12-19 2023-06-22 Massachusetts Institute Of Technology Compositions and methods for long-lasting germinal center responses to a priming immunization
WO2024064783A1 (en) 2022-09-21 2024-03-28 Wisconsin Alumni Research Foundation Compositions and methods to enhance therapeutic efficacy of cancer therapies
WO2024151642A1 (en) * 2023-01-09 2024-07-18 University Of Maryland, Baltimore Engineered anti-nociceptive-los competitive tlr4 ligands and methods for treating pain while maintaining immunosufficiency
WO2026087792A1 (en) 2024-10-27 2026-04-30 Idorsia Pharmaceuticals Ltd Vaccine against klebsiella pneumoniae

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI860747A7 (fi) * 1985-02-22 1986-08-23 Akzo Nv Nya 'lipid a'-typ disackarid- och trisackaridderivat.
WO2001036433A2 (en) * 1999-11-15 2001-05-25 Biomira, Inc. Synthetic lipid-a analogs and uses thereof
CN1306438A (zh) * 1998-05-07 2001-08-01 科里克萨有限公司 佐剂组合物及其使用方法
CN1606446A (zh) * 2000-05-19 2005-04-13 科里克萨有限公司 用单糖和二糖类化合物预防和治疗传染病和其他疾病的方法
CN1907289A (zh) * 2000-05-19 2007-02-07 科里克萨有限公司 用单糖和二糖类化合物预防和治疗传染病和其他疾病的方法
CN1928107A (zh) * 2001-03-30 2007-03-14 利里克萨有限公司 生产3-o-钝化-4’-单磷酰基脂a(3d-mla)的方法
WO2009035528A2 (en) * 2007-09-07 2009-03-19 University Of Georgia Research Foundation, Inc. Synthetic lipid a derivative

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066794A (en) 1984-08-24 1991-11-19 Daiichi Pharmaceutical Co., Ltd. Process for preparing a disaccharide derivative
JP2535048B2 (ja) 1988-02-29 1996-09-18 第一製薬株式会社 新規ジサッカライド誘導体及びその塩
JPH06206893A (ja) * 1992-09-07 1994-07-26 Suntory Ltd 新規なジサッカライド誘導体
WO1995007285A1 (en) 1993-09-07 1995-03-16 Suntory Limited Novel disaccharide derivative
PT729473E (pt) 1993-11-17 2001-02-28 Deutsche Om Arzneimittel Gmbh Dissacaridos de glucosamina metodo para a sua preparacao composicao farmaceutica contendo os mesmos e sua utilizacao
JPH10152497A (ja) * 1996-09-30 1998-06-09 Otsuka Pharmaceut Factory Inc ヘリコバクター・ピロリのリピドa
CA2333578C (en) 1998-07-14 2010-11-16 American Cyanamid Company Adjuvant and vaccine compositions containing monophosphoryl lipid a
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
GB0420634D0 (en) * 2004-09-16 2004-10-20 Glaxosmithkline Biolog Sa Vaccines
US7622128B2 (en) * 2005-12-13 2009-11-24 University Of Washington Porphyromonas gingivalis 1435/1449 LPS as an immune modulator
WO2008059307A2 (en) 2006-11-16 2008-05-22 Om Pharma Functionalized beta 1,6 glucosamine disaccharides and process for their preparation
US8563002B2 (en) * 2007-12-24 2013-10-22 Glaxosmithkline Biologicals, S.A. Recombinant RSV antigens
US9241988B2 (en) * 2012-04-12 2016-01-26 Avanti Polar Lipids, Inc. Disaccharide synthetic lipid compounds and uses thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI860747A7 (fi) * 1985-02-22 1986-08-23 Akzo Nv Nya 'lipid a'-typ disackarid- och trisackaridderivat.
CN1306438A (zh) * 1998-05-07 2001-08-01 科里克萨有限公司 佐剂组合物及其使用方法
WO2001036433A2 (en) * 1999-11-15 2001-05-25 Biomira, Inc. Synthetic lipid-a analogs and uses thereof
CN1606446A (zh) * 2000-05-19 2005-04-13 科里克萨有限公司 用单糖和二糖类化合物预防和治疗传染病和其他疾病的方法
CN1907289A (zh) * 2000-05-19 2007-02-07 科里克萨有限公司 用单糖和二糖类化合物预防和治疗传染病和其他疾病的方法
CN1928107A (zh) * 2001-03-30 2007-03-14 利里克萨有限公司 生产3-o-钝化-4’-单磷酰基脂a(3d-mla)的方法
WO2009035528A2 (en) * 2007-09-07 2009-03-19 University Of Georgia Research Foundation, Inc. Synthetic lipid a derivative

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KIYOSHI KAWASAKI,等: "Purification and characterization of deacylated and/or palmitoylated lipid A species unique to Salmonella enterica serovar Typhimurium", 《JOURNAL OF ENDOTOXIN RESEARCH》 *

Also Published As

Publication number Publication date
JP2018070652A (ja) 2018-05-10
JP6764396B2 (ja) 2020-09-30
HK1207383A1 (en) 2016-01-29
EP3674309A1 (en) 2020-07-01
CN104470938B (zh) 2017-07-28
US10143744B2 (en) 2018-12-04
CN104470938A (zh) 2015-03-25
JP2015512946A (ja) 2015-04-30
US9241988B2 (en) 2016-01-26
IN2014DN09392A (cg-RX-API-DMAC7.html) 2015-07-17
EP3674309B1 (en) 2024-09-11
EP2836499A1 (en) 2015-02-18
JP6271510B2 (ja) 2018-01-31
CA2870008A1 (en) 2013-10-17
ES2787876T3 (es) 2020-10-19
DK3674309T3 (da) 2024-11-25
CA2870008C (en) 2021-05-04
JP2020147579A (ja) 2020-09-17
EP2836499B1 (en) 2020-02-26
ES2992314T3 (es) 2024-12-11
JP7189906B2 (ja) 2022-12-14
EP2836499A4 (en) 2015-11-25
US20130273149A1 (en) 2013-10-17
US20160136271A1 (en) 2016-05-19
WO2013155448A1 (en) 2013-10-17

Similar Documents

Publication Publication Date Title
CN104470938B (zh) 二糖合成脂质化合物及其用途
US9518078B2 (en) Disaccharide synthetic lipid compounds and uses thereof
AU772429B2 (en) Transnasal transport/immunisation with highly adaptable carriers
US9827260B2 (en) Composition for buffered aminoalkyl glucosaminide phosphate compounds and its use for enhancing an immune response
KR20210027381A (ko) 신규 면역조절 소분자
AU705662B2 (en) Non-ionic surfactant vesicles as therapeutic agent
JP2025072463A (ja) 動力学的に作用するアジュバントアンサンブル
WO2008026781A1 (en) Reverse targeting lipid vesicle
HK1207383B (en) Disaccharide synthetic lipid compounds and uses thereof
US20170349618A1 (en) Disaccharide synthetic lipid compounds and uses thereof
JP2022505318A (ja) 吸入用乾燥医薬組成物
US20090306019A1 (en) Compositions for treatment of eosinophilia and related disorders
US20130122080A1 (en) Pharmaceutical composition capable of immuno-regulation or enhancement of immune response
JP4092367B1 (ja) リポソームおよびこれを含む免疫賦活活性用組成物。
WO2026085355A1 (en) Vaccine adjuvants and formulations thereof
US20060292173A1 (en) Multibacterial vaccines and uses thereof
US20060153869A1 (en) Multibacterial vaccines and uses thereof
CA2653226A1 (en) Liposomes and immunopotentiating compositions containing the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: Alabama

Applicant after: Avanti polar lipid Co.,Ltd.

Applicant after: AC Immune S.A.

Address before: alabama

Applicant before: AVANTI POLAR LIPIDS, Inc.

Applicant before: AC Immune S.A.

CB02 Change of applicant information